FIGURE
Fig. 4
- ID
- ZDB-FIG-220719-64
- Publication
- Bär et al., 2022 - Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 4
Measurement of tumour size grown on the chorioallantoic membranes of fertilised chicken eggs. (A) Tumour mass of HepG2 tumours after treatment with different concentrations of bb and PBS as control for 72 h. Data are presented as the mean ± SEM from seven independent experiments. *P<0.05. (B) Representative images of control and bb-treated HepG2 tumours after excision. Scale bar 800 µm. bb, broxbam; Ctrl, control. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Int. J. Oncol.